Norges Bank
NEOS

Norges Bank’s Neos Therapeutics, Inc NEOS Stock Holding History

Norges Bank’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-9,700
Closed -$204K – 2277
2015
Q3 		$204K Buy
+9,700
New +$214K ﹤0.01% 2237

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Norges Bank's NEOS Position: Q4 2015 in Review

Norges Bank sold out of Neos Therapeutics, Inc (NEOS) in Q4 2015, closing a stake of 9,700 shares — an estimated $204K sold.

Norges Bank first reported a position in NEOS in Q3 2015 and held it in 1 quarter. The position peaked at $204K in Q3 2015. 45 funds tracked by Wall St. Rank hold NEOS as of Q4 2015.

  • Norges Bank reported no remaining Neos Therapeutics, Inc position as of Q4 2015 after selling out during the quarter.
  • Norges Bank sold 9,700 Neos Therapeutics, Inc shares in Q4 2015, an estimated $204K.
  • Norges Bank first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 1 quarter.
  • Norges Bank's Neos Therapeutics, Inc position peaked at $204K in Q3 2015.
  • 45 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2015.

Based on Norges Bank's 13F filing for Q4 2015, filed 10 Feb 2016.